Pregled po CROSBI profilu: Eduard Vrdoljak (CROSBI Profil: 29490, MBZ: 205415)
Pronađeno 258 radova
-
1.Čerina, Dora; Krpina, Kristina; Jakopović, Marko; Dedić Plavetić, Natalija; Seiwerth, Fran; Tomić, Snježana; Radić, Jasna; Belac Lovasić, Ingrid; Canjko, Ivana; Boban, Marijo et al.The Challenges and Opportunities of the Implementation of Comprehensive Genomic Profiling in Everyday Clinical Practice with Non-Small Cell Lung Cancer: National Results from Croatia // Cancers, 15 (2023), 13; 3395, 11 doi:10.3390/cancers15133395 (međunarodna recenzija, članak, znanstveni)
-
2.Vrdoljak, Josip; Boban, Zvonimir; Barić, Domjan; Šegvić, Darko; Kumrić, Marko; Avirović, Manuela; Perić Balja, Melita; Milković Periša, Marija; Tomasović, Čedna; Tomić, Snježana et al.Applying Explainable Machine Learning Models for Detection of Breast Cancer Lymph Node Metastasis in Patients Eligible for Neoadjuvant Treatment // Cancers, 15 (2023), 3; 15030634, 17 doi:10.3390/cancers15030634 (međunarodna recenzija, članak, znanstveni)
-
3.Ban, Marija; Vrdoljak, EduardHER2-LOW NAPREDNO LIJEČENJE RAKA DOJKE] // Libri oncologici : Croatian journal of oncology, 50 (2022), 2-3; 118-125 doi:10.20471/lo.2022.50.02-03.18 (međunarodna recenzija, članak, znanstveni)
-
4.Petrić-Miše, Branka; Pešo, Mirko; Hrepić, Darijo; Telesmanić-Dobrić, Vesna; Vrdoljak, EduardTreatment outcomes of patients with brca-mutated, recurrent ovarian cancer in University Hospital Center Split // Libri Oncologici Croatian Journal of Oncology, 50 (2022), 1; 16-26 doi:10.20471/lo.2022.50.01.04 (međunarodna recenzija, članak, znanstveni)
-
5.Čerina, D.; Matković, V.; Katić, K.; Belac Lovasic, I.; Separovic, R.; Canjko, I.; Bajić, Ž.; Vrdoljak, E.41P Comprehensive genomic profiling in the management of ovarian cancer: National results from Croatia // Annals of oncology
Valencia, Španjolska: Elsevier BV, 2022. str. S399-S399 doi:10.1016/j.annonc.2022.04.059 (poster, međunarodna recenzija, sažetak, stručni) -
6.Tankova, Tsvetalina; Senkus, Elzbieta; Beloyartseva, Maria; Borstnar, Simona; Catrinoiu, Doina; Frolova, Mona; Hegmane, Alinta; Janež, Andrej; Krnić, Mladen; Lengyel, Zoltan et al.Management Strategies for Hyperglycemia Associated with the alpha-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer // Cancers, 14 (2022), 7; 1598, 14 doi:10.3390/cancers14071598 (međunarodna recenzija, pregledni rad, znanstveni)
-
7.Lawler, Mark; ...; Vrdoljak, Eduard; ...; Sullivan, RichardEuropean Groundshot-addressing Europe's cancer research challenges: a Lancet Oncology Commission // Lancet oncology, (2022), 12; 128-131 doi:10.1016/S1470-2045(22)00540-X (međunarodna recenzija, članak, znanstveni)
-
8.Čeprnja, Toni; Mrklić, Ivana; Perić Balja, Melita; Marušić, Zlatko; Blažičević, Valerija; Spagnoli, Giulio Cesare; Juretić, Antonio; Čapkun, Vesna; Tečić Vuger, Ana; Vrdoljak, Eduard; Tomić, SnježanaPrognostic Significance of Lymphocyte Infiltrate Localization in Triple-Negative Breast Cancer // Journal of personalized medicine, 12 (2022), 6; 941, 14 doi:10.3390/jpm12060941 (međunarodna recenzija, članak, znanstveni)
-
9.Čerina, Dora; Boraska Jelavić, Tihana; Buljubašić Franić, Matea; Tomić, Krešimir; Bajić, Žarko; Vrdoljak, EduardIs There a Place for Adjuvant Chemotherapy in the Treatment of Locally Advanced Cervical Cancer? // Current Oncology, 29 (2022), 8; 5223-5237 doi:10.3390/curroncol29080415 (međunarodna recenzija, pregledni rad, znanstveni)
-
10.Belac Lovasić, Ingrid; Bašić Koretić, Martina; Podolski, Paula; Dedić Plavetić, Natalija; Silovski, Tajana; Pleština, Stjepko; Jazvić, Marijana; Soldić, Željko; Šeparović, Robert; Tečić Vuger, Ana et al.Smjernice Hrvatskoga onkološkog društva za dijagnozu, liječenje i praćenje bolesnica/ka oboljelih od invazivnog raka dojke (HOD RD-3) // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 144 (2022), 9-10; 295-305 doi:10.26800/lv-144-9-10-2 (međunarodna recenzija, pregledni rad, znanstveni)
-
11.Čerina, Dora; Matković, Višnja; Katić, Kristina; Belac Lovasić, Ingrid Belac; Šeparović, Robert; Canjko, Ivana; Bajić, Žarko; Vrdoljak, EduardComprehensive Genomic Profiling in the Management of Ovarian Cancer—National Results from Croatia // Journal of Personalized Medicine, 12 (2022), 7; 1176, 11 doi:10.3390/jpm12071176 (međunarodna recenzija, članak, znanstveni)
-
12.Prejac, Juraj; Omrčen, Tomislav; Radić, Jasna; Vrdoljak, Eduard; Fröbe, Ana; Pleština, StjepkoA multicenter exploratory analysis of the possible predictive factors for trifluridine/tipiracil in refractory metastatic colorectal cancer // Abstract Book of the ESMO 24th World Congress on Gastrointestinal Cancer 2022. U: Annals of Oncology 2022 ; 33(Supplement 4) / André, F. (ur.).
Lugano: Elsevier, 2022. str. S316-S316 doi:10.1016/j.annonc.2022.04.276 (poster, međunarodna recenzija, sažetak, stručni) -
13.Boraska Jelavić, Tihana; Podrug, Mario; Ban, Marija; Belac Lovasić, Ingrid; Curić, Zvonimir; Vrdoljak, EduardThe relevance of macrocytosis induction during neoadjuvant dose-dense chemotherapy in breast cancer patients. // Anti-cancer drugs, 33 (2022), 1; e655-e661 doi:10.1097/CAD.0000000000001223 (međunarodna recenzija, članak, znanstveni)
-
14.Lawler, Mark; Oliver, Kathy; Gijssels, Stefan; Aapro, Matti; Abolina, Agnese; Albreht, Tit; Erdem, Sema; Geissler, Jan; Jassem, Jacek; Karjalainen, Sakari et al.The European Code of Cancer Practice // Journal of Cancer Policy, 28 (2021), 100282, 20 doi:10.1016/j.jcpo.2021.100282 (međunarodna recenzija, pregledni rad, znanstveni)
-
15.Tomić, Krešimir; Berić Jozić, Gordana; Parić, Ana; Marijanović, Inga; Lasić, Ivan; Soldo, Dragan; Vrdoljak, EduardChemobrachyradiotherapy and consolidation chemotherapy in treatment of locally advanced cervical cancer // Wiener klinische Wochenschrift, 133 (2021), 21-22; 1155-1161 doi:10.1007/s00508-021-01958-0 (međunarodna recenzija, članak, znanstveni)
-
16.Vrdoljak, Eduard; Perić Balja, Melita; Marušić, Zlatko; Avirović, Manuela; Blažičević, Valerija; Tomasović, Čedna; Čerina, Dora; Bajić, Žarko; Petrić Miše, Branka; Belac Lovasić, Ingrid et al.COVID-19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population- and Registry-Based Study // Oncologist, 26 (2021), 7; e1156-e1160 doi:10.1002/onco.13791 (međunarodna recenzija, članak, znanstveni)
-
17.Vrdoljak, Eduard; Gligorov, Joseph; Wierinck, Lieve; Conte, PierFranco; De Grève, Jacques; Meunier, Françoise; Palmieri, Carlo; Travado, Luzia; Walker, Andrew; Wiseman, Theresa et al.Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in Europe // The Breast, 55 (2021), 79-90 doi:10.1016/j.breast.2020.12.005 (međunarodna recenzija, pregledni rad, znanstveni)
-
18.Fröbe, Ana; Jakšić, Blanka; Matković, Višnja; Haller, Herman; Petrić Miše, Branka; Butorac, Dražan; Vujić, Goran; Kos, Marina; Boraska Jelavić, Tihana; Tomić, Snježana et al.Kliničke smjernice za dijagnozu, liječenje i praćenje bolesnica oboljelih od zloćudnih tumora tijela maternice // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 143 (2021), 11-12; 404-415 doi:10.26800/LV-143-11-12-2 (međunarodna recenzija, pregledni rad, znanstveni)
-
19.Prejac Juraj, Omrčen Tomislav, Radić Jasna, Froebe Ana, Vrdoljak Eduard, Pleština StjepkoPossible predictive factors for the effectiveness of trifluridine/tipiracil in refractory metastatic colorectal cancer. A multicenter exploratory analysis // Libri oncologici
Poreč, Hrvatska, 2021. str. 117-118 (poster, domaća recenzija, prošireni sažetak, znanstveni) -
20.Saratlija Novaković, Žana; Boban, Toni; Boraska Jelavić, Tihana; Omrčen, Tomislav; Šitum, Marijan; Ledina, Dubravka; Strikić, Ante; Rakuljić, Zdravka; Vilović, Katarina; Librenjak, Davor; Vrdoljak, EduardResults of treatment of muscle-invasive bladder cancer in University Hospital of Split: 2014-2021 // 14th Croatian oncology congress. Libri Oncologici. 2021 ; 49 (Supplement 1).
Zagreb: Klinika za tumore, 2021. str. 125-125 (poster, domaća recenzija, sažetak, stručni) -
21.Vrdoljak, Eduard; Magri, Claude; Gamulin, Marija; Bošković, Lidija; Omrčen, Tomislav; Bajić, Žarko; Dienes, Tamas; Geczi, LajosReal-world safety and efficacy of nivolumab for ≥ 2nd line treatment of metastatic renal cell carcinoma: A retrospective cohort study in Croatia, Hungary, and Malta // Neoplasma, 68 (2021), 1; 208-215 doi:10.4149/neo_2020_200512N519 (međunarodna recenzija, članak, znanstveni)
-
22.Čerina, Dora; Matković, Višnja; Katić, Kristina; Lovasić, Ingrid Belac; Šeparović, Robert; Canjko, Ivana; Jakšić, Blanka; Fröbe, Ana; Pleština, Stjepko; Bajić, Žarko; Vrdoljak, EduardPrecision Oncology in Metastatic Uterine Cancer; Croatian First-Year Experience of the Comprehensive Genomic Profiling in Everyday Clinical Practice // Pathology oncology research, 27 (2021), 1609963, 8 doi:10.3389/pore.2021.1609963 (međunarodna recenzija, članak, znanstveni)
-
23.Čerina, Dora; Matković, Višnja; Katić, Kristina; Belac Lovasić, Ingrid; Šeparović, Robert; Canjko, Ivana; Jakšić, Blanka; Petrić Miše, Branka; Bajić, Žarko; Boban, Marijo et al.Real-World Efficacy and Safety of Bevacizumab in the First-Line Treatment of Metastatic Cervical Cancer: A Cohort Study in the Total Population of Croatian Patients // Journal of oncology, 2021 (2021), 2815623, 8 doi:10.1155/2021/2815623 (međunarodna recenzija, članak, znanstveni)
-
24.Vrdoljak, Eduard; Šekerija, Mario; Pleština, Stjepko; Belac Lovasić, Ingrid; Katalinić Janković, Vera; Garattini, Livio; Bobinac, Ana; Vončina, LukaIs it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer. // The European journal of health economics, 22 (2021), 3; 393-403 doi:10.1007/s10198-020-01262-0 (međunarodna recenzija, članak, znanstveni)
-
25.Majić, Ana; Urlić, Ivan; Pancirov, Marija; Paparella - Karaman, Ana; Strikić, Ante; Ban, Marija; Hrepić, Darijo; Vrdoljak, EduardHematotoxicity od cyclin dependent kynases 4/6 (CDK4/6) inhibitors palbociclib and ribocyclib during first 2 cycles of treatment of metastatic breast cancer – a restropective analysis in single centre // Poster presentation
online;, 2020. str. 99-99 (poster, podatak o recenziji nije dostupan, sažetak, znanstveni) -
26.Vrdoljak, Eduard; Sullivan, Richard; Lawler, MarkCancer and coronavirus disease 2019; how do we manage cancer optimally through a public health crisis? // European Journal of Cancer, 132 (2020), 98-99 doi:10.1016/j.ejca.2020.04.001 (međunarodna recenzija, pismo uredniku, stručni)
-
27.Omrčen Tomislav, Eterović Davor, Vrdoljak EduardPredictors of resistance to abiraterone acetate or enzalutamide in patients with metastatic castration-resistant prostate cancer in post- docetaxel setting: a single-center cohort study // Anti-cancer drugs, 31 (2020), 7; 742-746 doi:10.1097/CAD.0000000000000945 (međunarodna recenzija, članak, znanstveni)
-
28.Omrčen Tomislav, Katić Andrija, Tomić Snježana, Eterović Davor, Vrdoljak EduardPredictors of outcome in elderly patients with metastatic colorectal cancer: the final results of a prospective phase II study of bevacizumab in combination with capecitabine as first-line treatment // Anti-cancer drugs, 31 (2020), 5; 518-522 (međunarodna recenzija, članak, znanstveni)
-
29.Čerina D., Katić A., Paparella Karaman A., Hrepić D., Vrdoljak E.Molecular profiling frequency of metastatic colorectal carcinoma and it's impact on the outcomes: a single institution status report in 2017. // 13. Hrvatski onkološki kongres
Poreč, Hrvatska, 2020. 109, 3 (poster, sažetak, stručni) -
30.Pancirov M., Hrepić D., Vrdoljak E.Hepatotoxicity profiles of biosimilars v. generic antiher2 therapy in everyday clinical practice - observational study at the department of oncology and radiotherapy // 13. hrvatski onkološki kongres (HOK)
Poreč, Hrvatska, 2020. 110, 3 (poster, sažetak, znanstveni) -
31.Pancirov, Marija; Majić, Ana; Tomić, Snježana; Dolić, Krešimir; Krnić, Mladen; Petrić Miše, Branka; Vrdoljak, EduardFirst experience of alpelisib treatment of HR+ HER2- metastatic breast carcinoma in Croatia // Libri Oncologici 48(Suppl.1). Poster presentation / Vrdoljak, Danko Velimir (ur.).
Zagreb, 2020. str. 121-121 (poster, međunarodna recenzija, sažetak, stručni) -
32.Majić, Ana; Petrić Miše, Branka; Vrdoljak, EduardBRAF mutant metastatic melanoma: A case report // 13th Croatian oncology congress.Libri Oncologici. 2020 ; 48(Suppl 1) / Vrdoljak, Danko Velimir (ur.).
Zagreb, 2020. str. 53-53 (predavanje, međunarodna recenzija, sažetak, stručni) -
33.Ban, Marija; Petrić Miše, Branka; Vrdoljak EduardEarly HER2-Positive Breast Cancer: Current Treatment and Novel Approaches // Breast care, 15 (2020), 6; 560-568 doi:10.1159/000511883 (međunarodna recenzija, pregledni rad, znanstveni)
-
34.Majić, Ana; Petrić Miše, Branka; Matković, Višnja; Belac Lovasić, Ingrid; Katić, Kristina; Canjko, Ivana; Frobe, Ana; Bajić, Željko; Vrdoljak, EduardOlaparib outcomes in patients with BRCA 1-2 mutated, platinum-sensitive, recurrent ovarian cancer in Croatia: A retrospective noninterventional study // Journal of oncology, 2020 (2020), 64223936, 6 doi:10.1155/2020/6423936 (međunarodna recenzija, članak, znanstveni)
-
35.Mamić, Bisera; Boraska Jelavić, Tihana; Podrug, Mario; Ban, Marija; Vrdoljak, EduardNeoadjuvantno liječenje raka dojke u KBC Split // 12. hrvatski onkološki kongres : s međunarodnim sudjelovanjem : 04-07.04.2019, Poreč : knjiga sažetaka / Vrdoljak, Eduard (ur.).
Zagreb: Hrvatsko onkološko društvo HLZ-a, 2019. (predavanje, podatak o recenziji nije dostupan, ostalo, znanstveni) -
36.(AROME ; ESO) Todorović, Vladimir; Aapro, Matti; Pavlidis, Nicholas; Arsovski, Oliver; Belkacemi, Yazid; Babović, Nada; Bidard, Francois Clement; Bourhafour, Mouna; Bešlija, Semir; Boussen, Hamouda et al.AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan) // JBUON, 24 (2019), 5; 2180-2197 (međunarodna recenzija, članak, znanstveni)
-
37.Vrdoljak, Eduard; Bodoky, Gyorgy; Jassem, Jacek; Popescu, Razvan; Pirker, Robert; Čufer, Tanja; Bešlija, Semir; Eniu, Alexandru; Todorović, Vladimir; Kopečková, Katerina et al.Expenditures on Oncology Drugs and Cancer Mortality- to-Incidence Ratio in Central and Eastern Europe // The Oncologist, 24 (2019), 1; e30-e37 doi:10.1634/theoncologist.2018-0093 (međunarodna recenzija, članak, znanstveni)
-
38.Omrčen Tomislav, Eterović Davor, Vrdoljak EduardPredictors of resistance to abiraterone acetate (AA) or enzalutamide (ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-docetaxel setting // 11th European Multidisciplinary Congress on Urological Cancers: Implementing multidisciplinary strategies in genito-urinary cancers. European Urology Supplements. 2019 ; 18(11)
Beč, Austrija: Elsevier, 2019. str. 3491-3492 doi:10.1016/ S1569-9056(19)34647-0 (poster, međunarodna recenzija, prošireni sažetak, stručni) -
39.Omrčen Tomislav, Katic Andrija, Tomić Snježana, Eterović Davor, Vrdoljak EduardDoes metastatic colorectal cancer in elderly patients have specific features: the final results of prospective phase Iistudy of bevacizumab in combination with capecitabin // ESMO 21st World Congress on Gastrointestinal Cancer. Annals of Oncology. 2019 ; 30 (Supplement 4)
Barcelona, Španjolska, 2019. str. 65-65 doi:10.1093./annonc/mdz155.236 (poster, međunarodna recenzija, sažetak, stručni) -
40.Omrčen Tomislav, Puljić Ćuk Ana, Hrepić Darijo, Vrdoljak EduardTrifluridin-tipiracil u liječenju bolesnika s metastatskim rakom debelog crijeva u Klinici za onkologiju i radioterapiju u Splitu: retrospektivna analiza // Knjiga sažetaka
Poreč, Hrvatska, 2019. str. 78-78 (poster, domaća recenzija, sažetak, stručni) -
41.(AROME ; ESO) Todorović, Vladimir; Aapro, Matti; Pavlidis, Nicholas; Arsovski, Oliver; Belkacemi, Yazid; Babović, Nada; Bidard, François Clément; Bourhafour, Mouna; Bešlija, Semir; Boussen, Hamouda et al.AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME–Paris) and European School of Oncology (ESO – Milan) // JBUON, 24 (2019), 5; 2180-2197 (međunarodna recenzija, članak, znanstveni)
-
42.Majić, Ana; Mamić, Bisera; Buljubašić, Matea; Jazvo, Marija; Petrić Miše, Branka; Vrdoljak, EduardPredoperativna dijagnostička obrada pacijentica s rakom dojke prezentiranih na Multidisciplinarnom timu (MDT) Klinike za onkologiju i radioterapiju KBC-a Split u 2017. godini // Zbornik sažetaka
Poreč, Hrvatska, 2019. str. 72-72 (poster, domaća recenzija, sažetak, stručni) -
43.Petrić Miše, Branka; Katić, Andrija; Majić, Ana; Vrdoljak, EduardOlaparib u terapiji održavanja kod recidiva platina-osjetljivog karcinoma jajnika - iskustva Klinike za onkologiju i radioterapiju KBC Split // Zbornik sažetaka
Poreč, Hrvatska, 2019. str. 83-83 (poster, domaća recenzija, sažetak, stručni) -
44.Vrdoljak, Josip; Boban, Toni; Petrić Miše, Branka; Boraska Jelavić, Tihana; Bajić, Željko; Tomić, Snježana; Vrdoljak, EduardEfficacy and safety of TC dose-dense chemotherapy as first-line treatment of epithelial ovarian cancer: a single-institution retrospective cohort study // Japanese journal of clinical oncology, 49 (2019), 4; 347-353 doi:10.1093/jjco/hyz011 (međunarodna recenzija, članak, znanstveni)
-
45.Ban, Marija; Strikić, Ante; Petrić Miše, Branka; Vrdoljak, EduardUloga inhibitora CDK4/6 u liječenju hormonski ovisnoga metastatskog raka dojke negativnog na HER2 // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 141 (2019), 1-2; 33-39 doi:10.26800/lv-141-1-2-6 (međunarodna recenzija, članak, znanstveni)
-
46.Omrčen, Tomislav; Boraska Jelavić, Tihana; Šitum, Marijan; Vilović, Katarina; Dolić, Krešimir; Zahirović, Dag; Pavlović Ružić, Ira; Krpina, Kristian; Jazvić, Marijana; Ružić, Boris et al.Smjernice za dijagnosticiranje, liječenje i praćenje bolesnika s rakom bubrega // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 141 (2019), 11-12; 336-342 doi:10.26800/LV-141-11-12-43 (međunarodna recenzija, pregledni rad, znanstveni)
-
47.Kim, Tae Won; …; Vrdoljak, EduardFinal Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer // Clinical Colorectal Cancer, 17 (2018), 3; 206-214 doi:10.1016/j.clcc.2018.03.008 (međunarodna recenzija, članak, znanstveni)
-
48.Pivot, X.; Poole, C.; Martín, M.; Gligorov, J.; Barrios, C.H.; Vrdoljak, Eduard; Zambetti, M.; Woodward, N.; Ten Tije, A.J.; Lindegger, N. et al.The open-label, multinational, multicenter, Phase IIIB umbrella study of subcutaneous trastuzumab with or without chemotherapy or pertuzumab in patients (pts) with HER2-positive early breast cancer (EBC) or metastatic breast cancer (MBC): Pooled analysis of safety data from the UmbHER1 program // EUROPEAN JOURNAL OF CANCER
Barcelona, Španjolska: Elsevier BV, 2018. str. S105-S106 doi:10.1016/s0959-8049(18)30542-2 (poster, međunarodna recenzija, sažetak, stručni) -
49.Vrdoljak, Josip; Boban, T.; Petrić Miše, Branka; Boraska Jelavić, Tihana; Bajić, Z.; Tomić, Snježana; Vrdoljak, EduardEFFICACY AND SAFETY OF TC DOSE-DENSE CHEMOTHERAPY IN FIRST-LINE TREATMENT OF ADVANCED OVARIAN CANCER; A RETROSPECTIVE COHORT STUDY IN THE SINGLE INSTITUTION // INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Kyoto, Japan, 2018. str. 866-866 (poster, međunarodna recenzija, sažetak, stručni) -
50.Begum, Mursheda; Lewison, Grant; Jassem, Jacek; Mixich, Vlad; Cufer, Tanja; Nurgozhin, Talgat; Shabalkin, Pavel; Kutluk, Tezer; Voko, Zoltan; Radosavljevic, Davorin et al.Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planning // European journal of cancer, 104 (2018), 127-136 doi:10.1016/j.ejca.2018.08.024 (međunarodna recenzija, članak, znanstveni)
